Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
114 participants
INTERVENTIONAL
2013-04-23
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Melanoma Risk Assessment & Tailored Intervention
NCT01356771
Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma
NCT03028948
Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma
NCT03725449
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families
NCT03677739
Targeted Intervention for Melanoma Prevention
NCT00394134
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To test the effects of a behavior tracking and individually-tailored daily text message intervention on sun protection and exposure behaviors and to see if these techniques will be most effective in conjunction or separately.
SECONDARY OBJECTIVES:
I. To examine mediators in the effects of the intervention on safe sun behaviors, based on Fishbein?s Integrative Model.
OUTLINE: Patients are randomized to 1 of 4 study arms.
ARM I (SELF-MONITORING): Patients complete tanning and sun protection usage entries daily for 14 days.
ARM II (TEXT MESSAGES): Patients receive individualized text messages based on baseline assessment of tanning motives (appearance, enjoyment, social) daily for 14 days.
ARM III (COMBINED GROUP): Patients complete tanning and sun protection usage entries and also receive individualized text messages daily for 14 days.
ARM IV (CONTROL GROUP): Patients complete study assessments.
After completion of study, patients are followed up at 2 weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm I (self-monitoring)
ARM I (SELF-MONITORING): Patients complete tanning and sun protection usage entries daily for 14 days.
Compliance Monitoring
Record behavior
Questionnaire Administration
Ancillary studies
Arm II (text messages)
ARM II (TEXT MESSAGES): Patients receive individualized text messages based on baseline assessment of tanning motives (appearance, enjoyment, social) daily for 14 days.
Health Telemonitoring
Receive health monitoring text messages
Questionnaire Administration
Ancillary studies
Arm III (self-monitoring, text messages)
ARM III (COMBINED GROUP): Patients complete tanning and sun protection usage entries and also receive individualized text messages daily for 14 days.
Compliance Monitoring
Record behavior
Health Telemonitoring
Receive health monitoring text messages
Questionnaire Administration
Ancillary studies
Arm IV (questionnaire administration)
ARM IV (CONTROL GROUP): Patients complete study assessments.
Questionnaire Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Compliance Monitoring
Record behavior
Health Telemonitoring
Receive health monitoring text messages
Questionnaire Administration
Ancillary studies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
29 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Fox Chase Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carolyn Heckman
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carolyn Heckman
Role: PRINCIPAL_INVESTIGATOR
Fox Chase Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2015-02089
Identifier Type: REGISTRY
Identifier Source: secondary_id
IRB12846
Identifier Type: OTHER
Identifier Source: secondary_id
IRB12846
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.